0001209191-21-036315.txt : 20210527 0001209191-21-036315.hdr.sgml : 20210527 20210527180617 ACCESSION NUMBER: 0001209191-21-036315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210525 FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Jinzhu PhD CENTRAL INDEX KEY: 0001864373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 21974753 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-25 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001864373 Chen Jinzhu PhD 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Stock Options 5.14 2021-05-25 4 A 0 50000 0.00 A 2031-05-25 Common Stock 50000 50000 D One thirty-sixth of the shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, such that the shares subject to the option shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Person's continued service on the Board through each such vesting date. /s/Chase C. Leavitt, Attorney-in-fact 2021-05-27